ⓘ Lifastuzumab vedotin

                                     

ⓘ Lifastuzumab vedotin

Lifastuzumab vedotin is a monoclonal antibody designed for the treatment of cancer.

This drug developed by Genentech / Roche.

                                     
  • Sofituzumab vedotin Polatuzumab vedotin RG7596 Enfortumab vedotin Pinatuzumab vedotin Lifastuzumab vedotin Brentuximab vedotin Glembatumumab vedotin Indusatumab
  • Cotransporter Proteins, Type III TC 2.A.20 SLC20A1 PIT1 SLC20A2 PIT2 Lifastuzumab vedotin is a monoclonal antibody for the sodium phosphate cotransporter that
  • Commercialization Rights for RENCAREX NCI Drug Dictionary: Glemtumumab vedotin Results from Cure Brain Cancer Foundation - funded trial show promise